If you are having problems viewing this email click here

N8 EBULLETIN 28 OCTOBER 2011

This month we have been working on new ways to develop exciting research collaborations through the use of capital assets and equipment across the 8 universities. We received some great input to our project from national stakeholders including HEFCE, BIS and 3 Research Councils. The report from the workshop can be viewed on our website.

We have also formed a new network in Parasitology, to maximise the range of capabilities across the N8 universities, including biochemistry, genetics, anthropology and sociology.

Finally, we are delighted that two N8 supported companies, Reinnervate and QuantuMDx, have been shortlisted for the Cels Business for Life Awards 2011, while QuantumMDx has signed an exclusive license agreement supporting their innovation and growth in diagnostic and sequencing technologies.

We hope you find this ebulletin interesting and informative, and welcome your feedback.

With warm regards,

Sarah Jackson
N8 Research Partnership

 

N8 Asset Collaboration Workshop

We have compiled a conference report from the launch of our research programme on the Impacts of Demographic Change in the North of England.

The report contains input from Minister for Universities and Science, Rt Hon David Willetts MP and over 80 delegates from Local Authorities, Local Economic Partnerships, Business, Government, Voluntary Sector, Housing Consortiums and universities.

Click here to view the workshop report.

 

Demographics Conference Report

We have compiled a conference report looking at the economic impacts of demographic change in the North of England.

Based on the Demographic Change Research Launch held in September, the report contains input from Minister for Universities and Science, Rt Hon David Willetts MP and over 80 delegates from Local Authorities, Local Economic Partnerships, Business, Government, Voluntary Sector, Housing Consortiums and universities.

The report is now available to view online.

 

N8 Parasitology Network Created to Help Those Exposed to Parasitic Infections

The N8 Parasitology Network has been formed to take advantage of the opportunities across the N8 partnership of universities. Led by Durham University and consisting of more than 40 academics and dozens of post-doctoral and PhD students, the Network is addressing many key issues including the development of vaccines, diagnostic tools and drugs.

Click here to read more.

 

N8 CENTRE NEWS

 

N8 Research Partnership Supports Next Generation Diagnostic and Sequencing Technologies

QuantuMDx Group Limited, a leading handheld diagnostics and sequencing devices company based in Newcastle upon Tyne, UK and supported by the N8 Research Partnership, has signed an exclusive license agreement with NanoSys Inc, an advanced materials architect. The deal includes several patents and patent applications related to the use of nanostructures for biosensors.

Click here to read more.

 

Regener8 and METRC Members Shortlisted for Healthcare Awards

Regener8 member Reinnervate and METRC member QuantuMDX have been shortlisted for two categories at the Cels Business for Life Awards 2011.

The Awards celebrate the achievements of the Healthcare and Life Sciences Sector in the North of England in areas such as Innovation and Outstanding Growth. These awards not only recognise and reward the North of England’s top companies in the industry but also promote new technologies and companies to the region’s healthcare sector.

Click here to read more.

 

Follow us on Twitter

To be kept updated on the latest news from the N8 Research Partnership, please follow us on Twitter.

Click here to follow us on Twitter.

 
 

You are receiving this email because you have subscribed to the N8 Research Partnership mailing list.

Unsubscribe from future emails.

It's your responsibility to make sure this email is virus free. The N8 Research Partnership accept no responsibility for any loss or damage in any way arising from its use. Please save a tree and only print this email if necessary.

103.28.41.12